بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان
Background: Various studies have shown that the risk of apolipoprotein-A (apo-A), B (apo-B), and trans fatty acids may be different for cardiovascular disease (CVD) events in different populations. This study aimed to estimate the relative risk of apo-A, apo-B, and trans fatty acids for the occurren...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Vesnu Publications
2011-03-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/833 |
id |
doaj-2e85e1c5ed20446786ef6903fba8526f |
---|---|
record_format |
Article |
spelling |
doaj-2e85e1c5ed20446786ef6903fba8526f2020-11-25T01:05:14ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2011-03-012812419671977522بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهانNizal Sarrafzadegan0Sedigheh Asgari1Nafiseh Toghianifar2Mohammad Talaei3Aliakbar Tavassoli4Maryam Boshtam5Masoumeh Sadeghi6Professor, Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Pharmacognosist, Basic Sciences, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfa-han, Iran.General Practitioner, Quality Control Unit, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.General Practitioner, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Cardiologist, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.MSc in Physiology, Laboratory of Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Associate Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Background: Various studies have shown that the risk of apolipoprotein-A (apo-A), B (apo-B), and trans fatty acids may be different for cardiovascular disease (CVD) events in different populations. This study aimed to estimate the relative risk of apo-A, apo-B, and trans fatty acids for the occurrence of cardiovascular disease events in a cohort study. Methods: A cohort study was performed on 5375 subjects aged ≥ 35 years old participating in the Isfahan Healthy Heart Program (IHHP) that had been recruited with multistage cluster random sampling method. Apo-A and apo-B were measured in all subjects while trans fatty acids were measured on a random sample of 238 subjects. The relative risk of these factors for CVD events was defined in a 6-year period. T-test was used to compare means. Logistic regression and Cox regression were used to calculate Hazard ratio of cardiovascular disease events. Finding: After adjustment for age and sex, the relative risk for cardiovascular disease events was 2.393 (95%CI 1.155-4.961) for apo-B/A, 1.007 (95%CI 1.004-1.009) for total cholesterol, 1.002 (95%CI 1.001-1.003) for triglycerides, and 1.008 (95%CI 1.005-1.010) for LDL-cholesterol. After adjustment for smoking, diabetes, hypertension, and obesity, the relative risk for total cholesterol (1.006, 95%CI 1.003-1.008) and LDL-cholesterol 1.007, 95%CI 1.004-1.010) was significant while insignificant for trans fatty acids. Conclusion: This study showed that relative risk of apo-B/A for cardiovascular disease events is similar to total cholesterol and LDL-cholesterol. However, after adjustment for other risk factors, the association remained significant only for total cholesterol and LDL-cholesterol. Trans fatty acids did not show significant risk for cardiovascular disease event.http://jims.mui.ac.ir/index.php/jims/article/view/833Cardiovascular diseaseApolipoproteinsTrans fatty acidsCohort studies |
collection |
DOAJ |
language |
fas |
format |
Article |
sources |
DOAJ |
author |
Nizal Sarrafzadegan Sedigheh Asgari Nafiseh Toghianifar Mohammad Talaei Aliakbar Tavassoli Maryam Boshtam Masoumeh Sadeghi |
spellingShingle |
Nizal Sarrafzadegan Sedigheh Asgari Nafiseh Toghianifar Mohammad Talaei Aliakbar Tavassoli Maryam Boshtam Masoumeh Sadeghi بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان مجله دانشکده پزشکی اصفهان Cardiovascular disease Apolipoproteins Trans fatty acids Cohort studies |
author_facet |
Nizal Sarrafzadegan Sedigheh Asgari Nafiseh Toghianifar Mohammad Talaei Aliakbar Tavassoli Maryam Boshtam Masoumeh Sadeghi |
author_sort |
Nizal Sarrafzadegan |
title |
بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان |
title_short |
بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان |
title_full |
بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان |
title_fullStr |
بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان |
title_full_unstemmed |
بررسی ارتباط آپولیپوپروتئینهای A، B و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان |
title_sort |
بررسی ارتباط آپولیپوپروتئینهای a، b و اسیدهای چرب ترانس با حوادث قلبی- عروقی: مطالعهی هم گروهی برنامهی قلب سالم اصفهان |
publisher |
Vesnu Publications |
series |
مجله دانشکده پزشکی اصفهان |
issn |
1027-7595 1735-854X |
publishDate |
2011-03-01 |
description |
Background: Various studies have shown that the risk of apolipoprotein-A (apo-A), B (apo-B), and trans fatty acids may be different for cardiovascular disease (CVD) events in different populations. This study aimed to estimate the relative risk of apo-A, apo-B, and trans fatty acids for the occurrence of cardiovascular disease events in a cohort study.
Methods: A cohort study was performed on 5375 subjects aged ≥ 35 years old participating in the Isfahan Healthy Heart Program (IHHP) that had been recruited with multistage cluster random sampling method. Apo-A and apo-B were measured in all subjects while trans fatty acids were measured on a random sample of 238 subjects. The relative risk of these factors for CVD events was defined in a 6-year period. T-test was used to compare means. Logistic regression and Cox regression were used to calculate Hazard ratio of cardiovascular disease events.
Finding: After adjustment for age and sex, the relative risk for cardiovascular disease events was 2.393 (95%CI 1.155-4.961) for apo-B/A, 1.007 (95%CI 1.004-1.009) for total cholesterol, 1.002 (95%CI 1.001-1.003) for triglycerides, and 1.008 (95%CI 1.005-1.010) for LDL-cholesterol. After adjustment for smoking, diabetes, hypertension, and obesity, the relative risk for total cholesterol (1.006, 95%CI 1.003-1.008) and LDL-cholesterol 1.007, 95%CI 1.004-1.010) was significant while insignificant for trans fatty acids.
Conclusion: This study showed that relative risk of apo-B/A for cardiovascular disease events is similar to total cholesterol and LDL-cholesterol. However, after adjustment for other risk factors, the association remained significant only for total cholesterol and LDL-cholesterol. Trans fatty acids did not show significant risk for cardiovascular disease event. |
topic |
Cardiovascular disease Apolipoproteins Trans fatty acids Cohort studies |
url |
http://jims.mui.ac.ir/index.php/jims/article/view/833 |
work_keys_str_mv |
AT nizalsarrafzadegan brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn AT sedighehasgari brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn AT nafisehtoghianifar brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn AT mohammadtalaei brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn AT aliakbartavassoli brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn AT maryamboshtam brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn AT masoumehsadeghi brrsyạrtbạṭậpwlypwprwtỷynhạyabwạsydhạycẖrbtrạnsbạḥwạdtẖqlbyʿrwqymṭạlʿhyhmgrwhybrnạmhyqlbsạlmạṣfhạn |
_version_ |
1725195439436726272 |